Member Login
  1. Stocks
    2. /
  2. Imv (TSX: IMV)
    3. /

TSX:IMV (Imv)

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Imv (TSX: IMV) Latest News

    Stocks for Beginners

    3 Under-$5 TSX Stocks That Could Double in a Year

    | Jitendra Parashar

    Bay Street analysts expect these three under-$5 stocks to more than double within a year. Buy them today to get…

    Read more »

    Investing

    Value Investing: 1 Pharma Stock to Buy in June 2021

    | Nikhil Kumar

    IMV (TSX:IMV)(NASDAQ:IMV) is a biopharmaceutical company that gives patients with hard-to-treat cancers a chance to enjoy a long and healthy…

    Read more »

    Investing

    44% of Canadians Will Get Cancer: This 1 Stock Will Skyrocket!

    | Chen Liu

    IMV Inc. (TSX:IMV)(NASDAQ:IMV) specializes in making immunotherapies more effective, add the stock to your TFSA or RRSP today!

    Read more »

    Dividend Stocks

    Cure Recession Blues With These Red-Hot Healthcare Stocks

    | Victoria Hetherington

    Viemed Healthcare Inc. (TSX:VMD) and one other medical stock could reward Canadian investors with upside, even despite a recession.

    Read more »

    Dividend Stocks

    3 Top Canadian Healthcare Stocks for Growth Investors

    | Victoria Hetherington

    Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and two other healthcare stocks may have flown under the radar of recession-proofing investors.

    Read more »

    Investing

    2 Biotech Stocks at 52-Week Lows: Should You Buy Today?

    | Ambrose O'Callaghan

    IMV Inc. (TSX:IMV)(NASDAQ:IMV) and Fennec Pharmaceuticals Inc. (TSX:FRX)(NASDAQ:FENC) reached 52-week lows over the last week of trading.

    Read more »

    Dividend Stocks

    Casual Investors: 3 Low-Risk, High-Growth Stocks

    | Victoria Hetherington

    Questor Technology Inc. (TSX:QST) and two other stocks look like surprisingly defensive plays on today’s watch list.

    Read more »